ECCMID 2024 Resource Center
View and download educational content presented by at ECCMID 2024, including a recording of our workshop, as well as scientific posters.

Innovation and Pipeline Theater presentation:

Critical results for critical sample

Speaker: 

Federico Pea, MD, FISAC Full Professor of Pharmacology, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Italy; Head SSD Clinical Pharmacology - Dept. Integrated Management of Infectious Risk University Hospital IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy 

Description:

Accurate minimum inhibitory concentration (MIC) data, therapeutic drug monitoring, and biomarker utilization are highly significant in supporting a clinician’s decisions in optimizing dosing and improving patient outcomes.

Explore how making therapeutic choices based on these factors can positively impact treatment effectiveness. Discover the crucial role of the microbiology laboratory and the selection of the appropriate AST method in helping clinicians determine suitable treatment for critically ill patients with severe infections. And gain insights into the potential consequences of delayed or inaccurate results, especially for patients with multi-drug resistant infections, which can lead to suboptimal guidance for clinicians.

Watch presentation
Current Time 0:00
Duration 17:17
Loaded: 0.95%
Stream Type LIVE
Remaining Time 17:17
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected

    Posters:

     

    Comparison of AI-assisted and manual interpretation of disc diffusion test from 12 antibiotics of Pseudomonas aeruginosa 

      
     Evaluation of the equivalency of the Oxoid aztreonam/avibactam (30/20 μg) antimicrobial susceptibility testing disc to the CLSI M07 broth microdilution frozen reference method
      
     Evaluation of the Oxoid imipenem/relebactam (10/25 µg) antimicrobial susceptibility testing (AST) disc against the predicate AST disc
    Brilliance-poster-sample-request-form-poster-thumbnail-270x195

    Special offer: Celebrating 100 years of culture media brilliance

    Request our Thermo Scientific™ Brilliance™ chromogenic media lab poster and a no-charge evaluation sample.*

    Request offer

    Additional resources:

    SmartNote: Guiding treatment decisions for the critically ill - when is a true MIC not a true MIC?

    SmartNote: Guiding treatment decisions for the critically ill - when is a true MIC not a true MIC?

    Download our latest white paper to hear directly from the experts on the impact of definitive minimum inhibitory concentration (MIC) results on therapeutic treatment decisions and patient care

    Download SmartNote

    Infographic: Diagnostics in the antimicrobial stewardship jigsaw

    Infographic: Diagnostics in the antimicrobial stewardship jigsaw

    Antimicrobial stewardship is a major weapon in the war on AMR – and effective diagnostics are a crucial part of the jigsaw puzzle. Because if we do not act, including using new and existing antibiotics as responsibly as possible, deaths from this “silent pandemic” could rise dramatically in the years ahead.

    Download infographic

    Learn more about the solutions that were presented at ECCMID 2024 at thermofisher.com/eccmid.

    Products are distributed in the U.S. and Europe so uses, applications, and availability of product in each country depend on local regulatory marketing authorization status. © 2024 Thermo Fisher Scientific Inc. . Clever Culture Systems is the legal manufacturer of the APAS® Independence. APAS® is a trademark of Clever Culture Systems. The APAS Independence is distributed in the U.S. and Europe by Thermo Fisher Scientific.